Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study
尼波卡利单抗（一种抗FcRn单克隆抗体）用于治疗对TNF抑制剂治疗反应不足或不耐受的中重度活动性类风湿关节炎患者：来自2a期IRIS-RA研究的结果
期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2024-004278
Taylor, Peter C; Schett, Georg; Huizinga, Tom Wj; Wang, Qingmin; Ibrahim, Fowzia; Zhou, Bei; Liva, Sophia G; Shaik, Jafar Sadik B; Xiong, Yuan; Leu, Jocelyn H; Panchakshari, Rohit A; Loza, Matthew J; Ma, Keying; Dhatt, Harman; Rojo Cella, Ricardo; Karyekar, Chetan S; Cuff, Carolyn A; Gao, Sheng; Fei, Kaiyin
